Pembrolizumab frente a placebo después de la cirugía y la radiación en participantes con carcinoma de células escamosas cutáneo localmente avanzado
This is a randomized, double-blind, study that compares pembrolizumab (MK-3475) with placebo given as adjuvant therapy in participants with high-risk locally advanced cutaneous squamous cell carcinoma (LA cSCC) that have undergone